462 related articles for article (PubMed ID: 30755367)
21. Establishment of an Ebola Treatment Unit and Laboratory - Bombali District, Sierra Leone, July 2014-January 2015.
Gleason B; Redd J; Kilmarx P; Sesay T; Bayor F; Mozalevskis A; Connolly A; Akpablie J; Prybylski D; Moffett D; King M; Bass M; Joseph K; Jones J; Ocen F
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1108-11. PubMed ID: 26447483
[TBL] [Abstract][Full Text] [Related]
22. Community health workers during the Ebola outbreak in Guinea, Liberia, and Sierra Leone.
Miller NP; Milsom P; Johnson G; Bedford J; Kapeu AS; Diallo AO; Hassen K; Rafique N; Islam K; Camara R; Kandeh J; Wesseh CS; Rasanathan K; Zambruni JP; Papowitz H
J Glob Health; 2018 Dec; 8(2):020601. PubMed ID: 30023054
[TBL] [Abstract][Full Text] [Related]
23. Ebola virus disease in health care workers--Sierra Leone, 2014.
Kilmarx PH; Clarke KR; Dietz PM; Hamel MJ; Husain F; McFadden JD; Park BJ; Sugerman DE; Bresee JS; Mermin J; McAuley J; Jambai A;
MMWR Morb Mortal Wkly Rep; 2014 Dec; 63(49):1168-71. PubMed ID: 25503921
[TBL] [Abstract][Full Text] [Related]
24. Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.
Conteh MA; Goldstein ST; Wurie HR; Gidudu J; Lisk DR; Carter RJ; Seward JF; Hampton LM; Wang D; Andersen LE; Arvay M; Schrag SJ; Dawson P; Fombah AE; Petrie CR; Feikin DR; Russell JBW; Lindblad R; Kargbo SAS; Samai M; Mahon BE
J Infect Dis; 2018 May; 217(suppl_1):S33-S39. PubMed ID: 29788347
[TBL] [Abstract][Full Text] [Related]
25. [Control of Ebola hemorrhagic fever: vaccine development and our Ebola project in Sierra Leone].
Watanabe T; Kawaoka Y
Uirusu; 2016; 66(1):53-62. PubMed ID: 28484179
[TBL] [Abstract][Full Text] [Related]
26. Barriers and facilitators to reporting deaths following Ebola surveillance in Sierra Leone: implications for sustainable mortality surveillance based on an exploratory qualitative assessment.
Jalloh MF; Kinsman J; Conteh J; Kaiser R; Jambai A; Ekström AM; Bunnell RE; Nordenstedt H
BMJ Open; 2021 May; 11(5):e042976. PubMed ID: 33986045
[TBL] [Abstract][Full Text] [Related]
27. Notes from The Field: Ebola Virus Disease Cluster - Northern Sierra Leone, January 2016.
Alpren C; Sloan M; Boegler KA; Martin DW; Ervin E; Washburn F; Rickert R; Singh T; Redd JT;
MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(26):681-2. PubMed ID: 27388584
[TBL] [Abstract][Full Text] [Related]
28. Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
Jarrett OD; Seward JF; Fombah AE; Lindblad R; Jalloh MI; El-Khorazaty J; Dawson P; Burton D; Zucker J; Carr W; Bah MM; Deen GF; George PM; James F; Lisk DR; Pratt D; Russell JBW; Sandy JD; Turay P; Hamel MJ; Schrag SJ; Walker RE; Samai M; Goldstein ST
J Infect Dis; 2018 May; 217(suppl_1):S24-S32. PubMed ID: 29788346
[TBL] [Abstract][Full Text] [Related]
29. When free healthcare is not free. Corruption and mistrust in Sierra Leone's primary healthcare system immediately prior to the Ebola outbreak.
Pieterse P; Lodge T
Int Health; 2015 Nov; 7(6):400-4. PubMed ID: 25908714
[TBL] [Abstract][Full Text] [Related]
30. Rapid assessment of Ebola infection prevention and control needs--six districts, Sierra Leone, October 2014.
Pathmanathan I; O'Connor KA; Adams ML; Rao CY; Kilmarx PH; Park BJ; Mermin J; Kargbo B; Wurie AH; Clarke KR;
MMWR Morb Mortal Wkly Rep; 2014 Dec; 63(49):1172-4. PubMed ID: 25503922
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
Zhu FC; Wurie AH; Hou LH; Liang Q; Li YH; Russell JB; Wu SP; Li JX; Hu YM; Guo Q; Xu WB; Wurie AR; Wang WJ; Zhang Z; Yin WJ; Ghazzawi M; Zhang X; Duan L; Wang JZ; Chen W
Lancet; 2017 Feb; 389(10069):621-628. PubMed ID: 28017399
[TBL] [Abstract][Full Text] [Related]
32. Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
Fombah AE; Goldstein ST; Jarrett OD; Jalloh MI; El-Khorazaty J; Lisk DR; Legardy-Williams J; Pratt DA; George PM; Russell JBW; Schrag SJ; Dawson P; Deen GF; Carr W; Lindblad R; James F; Bah MM; Yillia JF; Sandy JD; Turay PE; Conteh MA; Slutsker L; Mahon BE; Samai M; Seward JF
J Infect Dis; 2018 May; 217(suppl_1):S75-S80. PubMed ID: 29788342
[TBL] [Abstract][Full Text] [Related]
33. Considerations for use of Ebola vaccine during an emergency response.
Walldorf JA; Cloessner EA; Hyde TB; MacNeil A;
Vaccine; 2019 Nov; 37(48):7190-7200. PubMed ID: 28890191
[TBL] [Abstract][Full Text] [Related]
34. Learning from the challenges of Ebola Virus Disease contact tracers in Sierra Leone, February, 2015.
Ilesanmi OS
Pan Afr Med J; 2015; 22 Suppl 1(Suppl 1):21. PubMed ID: 26740849
[TBL] [Abstract][Full Text] [Related]
35. "We are the heroes because we are ready to die for this country": Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial.
Tengbeh AF; Enria L; Smout E; Mooney T; Callaghan M; Ishola D; Leigh B; Watson-Jones D; Greenwood B; Larson H; Lees S
Soc Sci Med; 2018 Apr; 203():35-42. PubMed ID: 29544144
[TBL] [Abstract][Full Text] [Related]
36. Operationalizing International Regulatory Standards in a Limited-Resource Setting During an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience.
Kabineh AK; Carr W; Motevalli M; Legardy-Williams J; Vincent W; Mahon BE; Samai M
J Infect Dis; 2018 May; 217(suppl_1):S56-S59. PubMed ID: 29788349
[TBL] [Abstract][Full Text] [Related]
37. Development of a set of community-informed Ebola messages for Sierra Leone.
Kinsman J; de Bruijne K; Jalloh AM; Harris M; Abdullah H; Boye-Thompson T; Sankoh O; Jalloh AK; Jalloh-Vos H
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005742. PubMed ID: 28787444
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Ebola virus disease surveillance system in Tonkolili District, Sierra Leone.
Ilesanmi OS; Fawole O; Nguku P; Oladimeji A; Nwenyi O
Pan Afr Med J; 2019; 32(Suppl 1):2. PubMed ID: 30984324
[TBL] [Abstract][Full Text] [Related]
39. Community Care Centre (CCC) as adjunct in the management of Ebola Virus Disease (EVD) cases during outbreaks: experience from Sierra Leone.
Olu O; Cormican M; Kamara KB; Butt W
Pan Afr Med J; 2015; 22 Suppl 1(Suppl 1):14. PubMed ID: 26740842
[TBL] [Abstract][Full Text] [Related]
40. Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda.
Kimbugwe G; Vatrinet R; Mwanga JA; Kakuru R; Mpeirwe D; Logoose S; Opio K; Kambale M; Seeley J; Grais RF; Marquer C; Kaleebu P; Ssali A
Vaccine; 2024 Apr; 42(12):3002-3008. PubMed ID: 38565464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
